5 amino 1mq clinical trial 5-Amino-1MQ — 50mg | NNMT Inhibitor (NAD+ Axis) 5-Amino-1MQ (5mg) | Third-Party Tested

Rotating sites may reduce irritation when multiple injections are needed

The IWRS allocated dispensing unit numbers for each patient, with the trial product dispensed by the site investigator or study coordinator at the trial site visits

Maintenance, dietary cause: oral tablets or twice-yearly injections

Ng Published: Endocrinology, Volume 142, Issue 12, December 2001, Pages 51825189 DOI: 10.1210/endo.142.12.8522 URL: Mouse and human cell lines were used to assess 3-adrenergic receptor (3-AR) mRNA expression, protein levels, and function following treatment with AOD9604 and human growth hormone (hGH)

It sets narrow and flawed diagnostic criteria and unfortunately set the tone for the following GP audits and it still largely influences diagnosis today